Phosphorylated and non-phosphorylated peptides, cover ing the sequence of IRF-3 (375-427), were prepared by an Fmoc solid-phase method with a peptide synthesizer model 433A (Applied Biosystems, Foster City, CA, USA), adopting software ver. 1.0.1 FastMoc 0.2511 MonPrevPK. Two phos phoserine residues were introduced using Fmoc-Ser[PO (OBzl)(0H)]. Peptides were purified by reversed-phase HPLC, and their purities were confirmed by amino acid analyses and MALD-TOF mass analyses. The peptides were finally dissolved in 6 M guanidine and then dialyzed against 20 mM Henes. off 7.9.
Luciferasse AssayLuciferase assays were performed as described previously (18). 
RESULTS
Homomeric Complex Formation of IRF-3-It has been reported that the IRF-3 homodimer (8) and IRF-3/IRF-7 heterodimer (13) are formed after induction . To examine the formation of a homomeric complex of IRF-3, a fusion construct of glutathione S transferase (GST) with IRF-.3 (GSTIRF-3) and p50 epitope-tagged IRF-3 (p50IRF-3) or mutants of it with amino acid substitutions, as described in Fig. IA and the substituted amino acids (bold letter) are indicated (right). (B) Ex pression of the GSTIRF-3 and IRF-3 mutants. L929 cells were transiently transfected with the GSTIRF-3 ex pression vector and either of the p50-tagged IRF-3 or mutants (lanes 1 and 2: wild type; lanes 3 and 4: S385A, S386A, T390A; lanes 5 and 6: S385A; lanes 7 and 8: S386A; lanes 9 and 10: 3A; lanes 11 and 12: IA). Cells were either mock treated (-) or infected with NDV (+) for 12 h. The whole cell lysates were subjected to immunoblot ting using anti-p50 epitope, anti-GST and anti-p300 antibodies, respectively. (C) Detection of the homomeric com plex of IRF-3. Whole cell lysates, as in dicated in )B), were precipitated with glutathione-Sepharose as described under "MATERIALS AND METH ODS." Lanes 1 to 12 correspond to the lanes in )B). Co-precipitated p50-tagged IRF-3 and endogenous p300 were detected by immunoblotting. ID) Dissociation of p300 from the homo meric complex of IRF-3 by DOC treat ment. Cells co-expressing GSTIRF-3 and p50-tagged IRF-3 were mock treated (-) or infected with NDV (+). The lysates were precipitated with glutathione-Sepharose in the absence (lanes 1 and 2) or presence of (lane 3) of 1(b DOC. The co-precipitated p50 -tagged IRF-3 and endogenous p300 were detected by immunoblotting (E) Effect of IRF-3 mutations of serine/ threonine residues on the transcrip tional activation potential. L929 cells were transiently transfected with the indicated effector constructs, together with the reporter construct containing repeated PRDI (p-55C1BLuc). The ef fector constructs were: the control vec tor (pEF-BOS; lanes 1 and 2), p50 -tagged IRF-3 (lanes 3 and 4), and p50-tagged IRF-3 mutants (5A, lanes 5 and 6; S385A, S386A, T390A, lanes 7 and 8; S385A, lanes 9 and 10; S386A, lanes 11 and 12( Luciferase activity was examined at 12h after mock (-) or NDV stimulation (+). Error bars show the standard error for quadruplicate transfections.
ting (Fig. 1) . The wild type p50IRF-3 formed a clear com plex with GSTIRF-3 after virus induction (Fig. 1C, lanes 1  and 2) . This is unlikely to be an artifact due to introduction GST The complex formed with the GSTIRF-3 was analyzed using an anti-p300 antibody (Fig. 1C, upper lanes) . p300 specifically associated with GSTIRF-3 after virus induction. The binding between p300 and phosphorylated IRF-3 is stable with high salt (1 M NaCI) or 8 M urea treatment (data not shown). We found that the addition of DOC (Irk) selectively abrogated the association of p300 with IRF-3, leaving the homomeric interaction unchanged (Fig. 1D) . Interestingly, the effect of DOC was reversible, and p300 and phosphorylated IRF-3 reassociated after removal of the DOC (data not shown).
As (7, 9-11, 13, 15) . To determine whether or not these IRFs are activated through a common molecular mechanism after phosphorylation by virus stimulation, we investigated the interaction between IRF-7 and p300. IRF -3 and IRF-7 were, respectively, expressed in L929 cells as fusion constructs with GST, and the cells were infected or not infected with a virus (Fig. 2) . The GST fusion constructs were precipitated with glutathione Sepharose and then the co-precipitated p300 was detected by immunoblotting. IRF 7 did not form a significant complex with p300 under these conditions. The results show the clearly distinct activation mechanisms of IRF-3 and IRF-7.
Binding of the Phosphorylated IRF-3 with p300-To ana lyze the interaction between phosphorylated IRF-3 and p300, we developed an in vitro assay. First, we delineated that a fragment of p300 with 470 amino acids (residues 1752-2221), which coincides with the glutamine-rich re gion, contains an interaction site for IRF-3 in co-precipita tion experiments (M.Y., unpublished data). A similar region of CBP (1992-2441) was reported to interact with IRF-3 (7). GSTAp300 fusion protein, which contains the above residues, was produced by insect cells (";MATERIALS AND METHODS") and immobilized on glutathione Sepharose beads. The resin was mixed with an extract of L929 cells which had been transfected with the human IRF-3 (hIRF 3) expression vector and then mock-treated or infected with a virus. The bound IRF-3 was separated from the unbound IRF-3 by washing and detected by immunoblotting. Since hIRF-3 was overexpressed due to transient transfection, the molar amount of hIRF-3 exceeded that of endogenous CBP/p300 in this experiment. However, as previously 1-394) . L929 cells were transiently transfected with a reporter construct (p-55CIBLuc) with either the control vector (pEF-BOS, lanes I and 2) or the expression plasmid for the HA-tagged IRF-3 (WT lanes 3 and 4) or HA-tagged deletion mutant (1-394, lanes 5 and 6). Cells were mock treated (-) or treated with NDV for 12h (+), and then subjected to the luciferase assay. Error bars show the standard error for quadruplicate transfections. (C) In vivo phosphorylation of IRF-3 5D and IRF-3 1-394) L929 cells transfected with pEF-p50IRF-3 (WT, lanes 1 and 2), pEF -HAIRF-3 (1-394, lanes 3 and 4), or pEF-p50IRF-3 (5D, lanes 5 and 6) were mock treated (-i or infected with NDV (+), and then cultured for 12 h in the presence of i"Plphosphate. IRF-3 was immunoprecipitated with anti-NES antibodies and separated by SDSPAGE, and then the phosphorylation of IRF-3 was examined by autoradiography (upper panel ). The whole cell lssate was subjected to immunoblotting using anti-NES antibodies (lower panel) . reported, virtually all hIRF-3 molecules showed a change in gel mobility after viral infection, indicating that they are specifically phosphorylated )15). The hIRF-3 from infected cells selectively bound to the recombinant p300 indicating that the phosphorylation of IRF-3 is necessary for the inter action (Fig. 3B, lanes 3 and 4) . Mutants which have substi tutions at potential phosphorylation sites (Fig. IA) were examined. As we reported earlier, mutation of the serines at positions 385 and/or 386 to alanine abolished the mobil ity change (Fig, 3A, lanes 5 to 10) . At the same time, inter action with p300 was also undetectable (Fig. 3B , lanes 5 to 10). Changes of these serines to acidic amino acids (S385D/ S386D or S385E/S386E) also abolished the inducible bind ing with p300 / Fig. 313, lanes 13 to 16) , indicating that the presence of a negative charge at these positions is not suffi cient for the interaction. These results show that phospho rylation of serine residues 385 and 386 is critical for specific binding with p300. On the other hand, mutations of the neighboring serine and threonine residues )T390A, 3A and 5A) did not abolish either the gel mobility change or the binding with p300 ( Fig. 3A and B, lanes 11 and 12, and 17 to 22). It is worth noting, however, that 5A binds to p300 less efficiently than the wild type, suggesting that these serines are phosphorylated and participate in the increase in the binding affinity.
Phosphorylated Residues of IRF-3 Directly Participate it the Interaction with p300-To further elucidate the role c serine residues 385 and 386, we chemically synthesized ppppptide corresponding to amino acids 375 to 427 with phos phate groups on serines 385 and 386. As a control, al unphosphorvlated peptide was also prepared. The peptide's ability to compete with the binding of IRF-3 to p300 was assayed in citro. Figure 4 shows that the phosphorylated peptide but not the unphosphorylated peptide prevented IRF-3 from binding to p300. The peptide did not affect the homomeric IRF-3 complex under the same conditions (unpublished observation). The result indicates that the phos phors'lated 53 mer peptide is sufficient for the specific rec ognition, and that the phosphorylation of residues 385 an 386 is conditional for the recognition. are Not Constitutioely Active in L929 showed that removal of the Cterminal residues of ] or substitution of the C-terminal serine/threonine cluster with aspartic acids [IRF-3(5D)] resulted in constitutive active IRF-3 when expressed in 293 cells. The function of these mutants was examined in our cell system using a multimerized PRDI luciferase reporter which exhibited low basal and high (>20 fold) virus-induced expression (Fig. 5A, lanes 1 and 2) .
As repeatedly shown, wild type IRF-3 did not affect the basal level of reporter expression (Fig. 5A, lanes 1 and 3) . The expression of IRF-3 (5D) did not augment the basal expression level either. Since comparable levels of the wild type IRF-3 and IRF-3 (5D) proteins were expressed (Fig.  5C) , we conclude that IRF-3 (5D) was not constitutively active in L929 cells. It is noteworthy that IRF-3 (5D) was hyper-phosphorylated in virus-infected cells as the wild type was (Fig. 5C , lanes 5 and 6). Likewise, IRF-3 (1-394), which was expressed at a com parable level to the wild type (Fig. 5C, lanes 3 and 4) , did not enhance the basal expression of the reporter (Fig. 5B) . In contrast to the wild type IRF-3, IRF-3 (1-394) did not transactivate after virus induction and even reduced the induced expression (Fig. 5B) . Consistent with this, IRF-3 (1-394) was only very weakly phosphorylated as compared with the wild type IRF-3 (Fig. 5C, lanes 3 and 4) Lin et al. (8) propose an intramolecular interaction between residues (98 to 240) and (380 to 427) of IRF-3 , and this interaction results in inhibition of homodimer forma tion and DNA binding. According to their model , the inhibi tion is reversed on the removal of residues (395 to 427) or phosphorylation of Ser/Thr clusters present within. How ever, our results showed that serines 385 and 386 are criti cal for the hornomeric complex as well as the holocomplex.
Furthermore, neither 5D nor IRF-3 (1-394) was constitu tively active in L929 cells (Fig. 5) . The discrepancies may be due to the different cell/virus combination and assays. However, we have no conclusive evidence explaining these discrepancies so far . Apparently more work , particularly elucidation of the three-dimensional structure of the IRF-3 molecule, is required to unequivocally understand the molecular suppression mechanism.
As shown previously, CBP/p300 is an essential compo nent for the DNA binding competent IRF-3 holocomplex (15). The induction of the DNA binding activity of an acti vator molecule through the association of the co-activator CBP/p300 is quite unique to IRF-3. This likely facilitates the dramatic switching on/off of the type I interferon genes . Although we analyzed p300 in the present study, CBP may behave similarly in IRF-3 activation (15). The phosphopep tide competition experiment showed that p300 directly rec ta izes an IRF-3 moiety including the phosphor lated serine residues. Thus the phospholylation of serines 385 and 386 may induce the homomeric and heteromeric inter actions through conformational change and generation of an interaction interface, respectively. Phosphorylation de pendent recognition between phosphorylated CREB and CBP has been established (24). The phosphor lated CREB domain (plUD) interacts with the KIX domain of CBP (25, 26) . However, the glutamine rich region with which IRF-3 interacts is distinct from the TUX domain, and no primary structure similarity can be found between pKID and IRF-3 (residues 375 to 427), suggesting a new class of phosphor lation dependent transcription factor-coactivator interac tion.
